130 related articles for article (PubMed ID: 9731060)
1. Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells.
Kapp U; Bhatia M; Bonnet D; Murdoch B; Dick JE
Blood; 1998 Sep; 92(6):2024-31. PubMed ID: 9731060
[TBL] [Abstract][Full Text] [Related]
2. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
Guenechea G; Segovia JC; Albella B; Lamana M; Ramírez M; Regidor C; Fernández MN; Bueren JA
Blood; 1999 Feb; 93(3):1097-105. PubMed ID: 9920860
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
[TBL] [Abstract][Full Text] [Related]
4. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
Piacibello W; Sanavio F; Severino A; Danè A; Gammaitoni L; Fagioli F; Perissinotto E; Cavalloni G; Kollet O; Lapidot T; Aglietta M
Blood; 1999 Jun; 93(11):3736-49. PubMed ID: 10339480
[TBL] [Abstract][Full Text] [Related]
5. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
Piacibello W; Bruno S; Sanavio F; Droetto S; Gunetti M; Ailles L; Santoni de Sio F; Viale A; Gammaitoni L; Lombardo A; Naldini L; Aglietta M
Blood; 2002 Dec; 100(13):4391-400. PubMed ID: 12453876
[TBL] [Abstract][Full Text] [Related]
7. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
Gothot A; van der Loo JC; Clapp DW; Srour EF
Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
[TBL] [Abstract][Full Text] [Related]
9. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice.
Bhatia M; Wang JC; Kapp U; Bonnet D; Dick JE
Proc Natl Acad Sci U S A; 1997 May; 94(10):5320-5. PubMed ID: 9144235
[TBL] [Abstract][Full Text] [Related]
10. Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment.
van Hennik PB; de Koning AE; Ploemacher RE
Blood; 1999 Nov; 94(9):3055-61. PubMed ID: 10556189
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.
Verstegen MM; van Hennik PB; Terpstra W; van den Bos C; Wielenga JJ; van Rooijen N; Ploemacher RE; Wagemaker G; Wognum AW
Blood; 1998 Mar; 91(6):1966-76. PubMed ID: 9490679
[TBL] [Abstract][Full Text] [Related]
12. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
Gan OI; Murdoch B; Larochelle A; Dick JE
Blood; 1997 Jul; 90(2):641-50. PubMed ID: 9226164
[TBL] [Abstract][Full Text] [Related]
13. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay.
Wang JC; Doedens M; Dick JE
Blood; 1997 Jun; 89(11):3919-24. PubMed ID: 9166828
[TBL] [Abstract][Full Text] [Related]
14. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model.
Bruno S; Gammaitoni L; Gunetti M; Sanavio F; Fagioli F; Aglietta M; Piacibello W
J Biol Regul Homeost Agents; 2001; 15(1):38-48. PubMed ID: 11388743
[TBL] [Abstract][Full Text] [Related]
15. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.
Veiby OP; Lyman SD; Jacobsen SE
Blood; 1996 Aug; 88(4):1256-65. PubMed ID: 8695843
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice.
Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K
Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074
[TBL] [Abstract][Full Text] [Related]
17. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
[TBL] [Abstract][Full Text] [Related]
18. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow.
Yahata T; Ando K; Sato T; Miyatake H; Nakamura Y; Muguruma Y; Kato S; Hotta T
Blood; 2003 Apr; 101(8):2905-13. PubMed ID: 12411299
[TBL] [Abstract][Full Text] [Related]
19. Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11.
Albella B; Segovia JC; Guenechea G; Pragnell IB; Bueren JA
Transplantation; 1999 May; 67(10):1348-57. PubMed ID: 10360589
[TBL] [Abstract][Full Text] [Related]
20. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
